Anagenics LimitedASX: AN1

Business Update

· Issued by Anagenics Limited

Filed with ASX · · 2 pages · English

Summary by 6ix AI

Anagenics Limited has completed the acquisition of Face Medi Group, enhancing its professional beauty platform and increasing pro-forma revenue significantly. Matthew Dudek has been appointed as the new Company Secretary, taking on additional responsibilities to support profit improvement initiatives. Dr Martin Cross has resigned as a Non-Executive Director, with the Board deciding not to replace him to maintain an appropriate board size.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Anagenics Limited on 6ix

Earlier from Anagenics

Later from Anagenics

All Anagenics news releases